Back to Search
RALPH ZINNER, M.D.
M.D.
Medical Oncology Physician
NPI: 1326132457IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
TP846(KY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1993
Research & Publications (20)
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.
PMID 19276160·Mol Cancer Ther·2009
4-observational
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
PMID 18556142·Int J Radiat Oncol Biol Phys·2009
3-trial
Multicolor 3D fluorescence in situ hybridization for imaging interphase chromosomes.
PMID 18951171·Methods Mol Biol·2008
8-other
Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer.
PMID 17505003·Clin Cancer Res·2007
3-trial
Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy.
PMID 17410030·J Thorac Oncol·2007
8-other
Biochemistry meets nuclear architecture: multicolor immuno-FISH for co-localization analysis of chromosome segments and differentially expressed gene loci with various histone methylations.
PMID 17442381·Adv Enzyme Regul·2007
4-observational
Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.
PMID 17762342·J Thorac Oncol·2007
3-trial
A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer.
PMID 17409987·J Thorac Oncol·2006
3-trial
Short-term restaging of patients with non-small cell lung cancer receiving chemotherapy.
PMID 17409894·J Thorac Oncol·2006
8-other
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
PMID 16943532·J Clin Oncol·2006
3-trial
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.
PMID 16640804·Clin Lung Cancer·2006
4-observational
Histone lysine methylation patterns in human cell types are arranged in distinct three-dimensional nuclear zones.
PMID 16215742·Histochem Cell Biol·2006
8-other
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
PMID 15930351·Clin Cancer Res·2005
3-trial
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
PMID 16258975·Cancer·2005
3-trial
Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer.
PMID 15897585·Clin Cancer Res·2005
3-trial
Pemetrexed in advanced NSCLC: a review of the clinical data.
PMID 15339061·Oncology (Williston Park)·2004
6-review
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.
PMID 15184994·Cancer Chemother Pharmacol·2004
3-trial
Three dimensional analysis of histone methylation patterns in normal and tumor cell nuclei.
PMID 15145772·Eur J Histochem·2004
8-other
Pemetrexed in the treatment of advanced non-small-cell lung cancer: a review of the clinical data.
PMID 15117428·Clin Lung Cancer·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- HEAD, NECK AND RESPIRATORY CLINIC, 800 ROSE STREET, 2ND FLOOR
LEXINGTON, KY 40536 - Phone
- (859) 257-4488
Quick Facts
- NPI
- 1326132457
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile